OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION (Page 2 of 2)

Warnings

For external use only

Do not use on damaged or broken skin

Stop use and ask a doctor if rash occurs

When using this product keep out of eyes. Rinse with water to remove.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • apply liberally 15 minutes before sun exposure
  • use a water resistant sunscreen if swimming or sweating
  • reapply at least every 2 hours
  • children under 6 months: Ask a doctor
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
    • limit time in the sun, especially from 10 a.m.–2 p.m.
    • wear long-sleeved shirts, pants, hats, and sunglasses

Inactive ingredients

1,2-hexanediol, caprylyl glycol, ceteareth-20, cetearyl alcohol, chlorphenesin, citric acid, cyclopentasiloxane, dimethicone, dimethicone crosspolymer-3, disodium EDTA, glycerin, hydrogenated palm glycerides, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, methylisothiazolinone, PEG-40 stearate, pentylene glycol, phenoxyethanol, phenyl trimethicone, polysilicone-11, polysorbate 60, potassium sorbate, sodium benzoate, sodium dihydroxycetyl phosphate, sodium polyacrylate, squalane, stearyl alcohol, tetrahexyldecyl ascorbate, tropolone, water, xanthan gum

Other information

  • store at controlled room temperature: 15°C–25°C (59°F–77°F)
  • protect this product from excessive heat and direct sun

Questions or comments?

1.800.636.7546
Monday–Friday 9 a.m.–4 p.m. Pacific Time

Store at controlled room temperature 15°C–25°C (59°F–77°F).

Obagi-C and the Obagi logo are registered trademarks of OMP, Inc.

Distributed by OMP, Inc., Long Beach, CA 90806

©2012 Obagi Medical Products, Inc. All rights reserved.
obagi.com Made in USA 41502211Z 5022

PRINCIPAL DISPLAY PANEL — Kit Carton

NDC# 62032-524-04

OBAGI®
MEDICAL

OBAGI-C® RX SYSTEM

NORMAL DRY
Skin Intervention Kit

PRINCIPAL DISPLAY PANEL -- Kit Carton
(click image for full-size original)
Established Pharmacological Class
Substance Pharmacological Class
OBAGI-C RX SYSTEM C-CLEANSINGWITH VITAMIN C Cleansing (cold creams, cleansing lotions, liquids, and pads)
OBAGI-C RX SYSTEM C-EXFOLIATING DAYWITH VITAMIN C Face and Neck (excluding shaving preparations)
OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION
hydroquinone, octinoxate and zinc oxide kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62032-524
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62032-524-04 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE, GLASS 30 mL
Part 2 1 BOTTLE, PLASTIC 57 g
Part 3 1 TUBE 85 g
Part 4 1 BOTTLE, PLASTIC 177 mL
Part 5 1 BOTTLE, PLASTIC 57 g
Part 1 of 5
OBAGI-C RX SYSTEM C-CLARIFYING SERUM SKIN LIGHTENING SERUM WITH VITAMIN C
hydroquinone liquid
Product Information
Item Code (Source) NDC:62032-106
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
PROPYLENE GLYCOL
WATER
ASCORBIC ACID
SODIUM LAURYL SULFATE
PROPYLENE CARBONATE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62032-106-10 1 BOTTLE, GLASS in 1 CARTON contains a BOTTLE, GLASS
1 30 mL in 1 BOTTLE, GLASS This package is contained within the CARTON (62032-106-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 01/01/2004
Part 2 of 5
OBAGI-C RX SYSTEM C-THERAPY SKIN LIGHTENING WITH VITAMINS C AND E
hydroquinone cream
Product Information
Item Code (Source) NDC:62032-105
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
EDETATE DISODIUM
PPG-2 MYRISTYL ETHER PROPIONATE
TROLAMINE SALICYLATE
SODIUM LAURYL SULFATE
CETYL ALCOHOL
GLYCERIN
LACTIC ACID
.ALPHA.-TOCOPHEROL ACETATE
ASCORBIC ACID
SODIUM METABISULFITE
WATER
METHYLPARABEN
PROPYLPARABEN
BUTYLATED HYDROXYTOLUENE
PHENYL TRIMETHICONE
Product Characteristics
Color WHITE Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62032-105-36 57 g in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 01/01/2004
Part 3 of 5
OBAGI-C RX SYSTEM SUN SHIELD BROAD SPECTRUM SPF 50 MATTE SUNSCREEN
octinoxate and zinc oxide lotion
Product Information
Item Code (Source) NDC:62032-121
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OCTINOXATE (OCTINOXATE) OCTINOXATE 75 mg in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE 105 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
GLYCERIN
PHENOXYETHANOL
CYCLOMETHICONE 5
WATER
PEG-10 DIMETHICONE (600 CST)
PENTYLENE GLYCOL
STEARYL ALCOHOL
POLYOXYL 20 CETOSTEARYL ETHER
PHENYL TRIMETHICONE
PEG-40 STEARATE
DIMETHICONE
SODIUM DIHYDROXYCETYL PHOSPHATE
HYDROGENATED PALM GLYCERIDES
CITRIC ACID MONOHYDRATE
CETOSTEARYL ALCOHOL
.ALPHA.-TOCOPHEROL ACETATE
1,2-HEXANEDIOL
CAPRYLYL GLYCOL
TROPOLONE
CHLORPHENESIN
XANTHAN GUM
POTASSIUM SORBATE
SODIUM BENZOATE
TETRAHEXYLDECYL ASCORBATE
UBIDECARENONE
EDETATE DISODIUM
METHYLISOTHIAZOLINONE
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
SQUALANE
POLYSORBATE 60
SODIUM POLYACRYLATE (2500000 MW)
Product Characteristics
Color WHITE Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:62032-121-90 85 g in 1 TUBE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part352 02/21/2013
Part 4 of 5
OBAGI-C RX SYSTEM C-CLEANSING WITH VITAMIN C
inert gel
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
WATER
GLYCERIN
PHENOXYETHANOL
ETHYLPARABEN
ISOBUTYLPARABEN
BUTYLPARABEN
PROPYLPARABEN
METHYLPARABEN
ASCORBIC ACID
SODIUM LAUROYL OAT AMINO ACIDS
COCAMIDOPROPYL BETAINE
SODIUM LAURETH-3 SULFATE
ALOE VERA LEAF
SODIUM CHLORIDE
ALFALFA
CHAMOMILE
XANTHAN GUM
D&C RED NO. 33
FD&C YELLOW NO. 5
Product Characteristics
Color ORANGE Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 177 mL in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 01/01/2004
Part 5 of 5
OBAGI-C RX SYSTEM C-EXFOLIATING DAY WITH VITAMIN C
inert lotion
Product Information
Route of Administration TOPICAL DEA Schedule
Ingredients
Ingredient Name Quantity
WATER
GLYCERIN
PHENOXYETHANOL
ETHYLPARABEN
ISOBUTYLPARABEN
BUTYLPARABEN
PROPYLPARABEN
METHYLPARABEN
POLYSORBATE 60
GLYCERYL MONOSTEARATE
PEG-100 STEARATE
ETHYLHEXYL PALMITATE
SQUALANE
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
PEG-8 DIMETHICONE
PEG-8 RICINOLEATE
GLYCOLIC ACID
ARGININE
ETHYLHEXYL STEARATE
MEDIUM-CHAIN TRIGLYCERIDES
ISOPROPYL PALMITATE
HYALURONATE SODIUM
SODIUM HYDROXIDE
CETOSTEARYL ALCOHOL
POLYOXYL 20 CETOSTEARYL ETHER
DIMETHICONE
STEARETH-2
ASCORBYL GLUCOSIDE
LEVOMENOL
EDETATE SODIUM
.ALPHA.-TOCOPHEROL ACETATE
Product Characteristics
Color WHITE Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 57 g in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 01/01/2004
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 04/02/2013
Labeler — OMP, INC. (790553353)
Establishment
Name Address ID/FEI Operations
PURETEK CORPORATION 785961046 MANUFACTURE (62032-524), LABEL (62032-524), PACK (62032-524)
Establishment
Name Address ID/FEI Operations
Ei INC. 105803274 MANUFACTURE (62032-524), LABEL (62032-524), PACK (62032-524), ANALYSIS (62032-524)
Establishment
Name Address ID/FEI Operations
MILBAR LABORATORIES 195556790 MANUFACTURE (62032-524)
Establishment
Name Address ID/FEI Operations
Bay Cities Container Corporation 066229618 RELABEL (62032-524), REPACK (62032-524)

Revised: 08/2013 OMP, INC.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.